EMA Guide To Help Regulators Assess Subgroup Analyses In Confirmatory Trials
A new final guidance by the European Medicines Agency outlines broad principles and strategies that regulatory assessors can use when investigating subgroups in confirmatory clinical trials.
You may also be interested in...
The European Medicines Agency has identified key areas where stakeholders want to see it deliver a real change over the next five years.
While inspection interviews can be stressful for drug firms, a Dutch pharmacovigilance inspector reassures companies that any responses made during the process cannot undo any good work they have already done. And they can also correct any wrong answers later on.
The Saudi Food & Drug Authority looks at the number of individual case safety reports (ICSRs) submitted by a company, among other risk-based factors, when drawing up its list for routine pharmacovigilance inspections.